We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
Megacap tech names led the broader market to another record close as Nvidia hit a new intraday all...
Read ArticleMegacap tech names led the broader market to another record close as Nvidia hit a new intraday all t...
Read ArticleCyclical stocks and those leveraged to manufacturing activity came under pressure during the tradi...
Read ArticleCyclical stocks and those leveraged to manufacturing activity came under pressure during the trading...
Read ArticleS&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biot...
Read ArticleResearch shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase th...
Read ArticleASX Health sector was in correction territory in April Why is the health sector different from othe...
Read ArticleThere’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to c...
Read ArticlePercheron could double if clinical goes well But Taylor Collison admits that PER is a speculative i...
Read ArticleMoneyTalks is Stockhead’s regular drill down into what stocks investors are looking at right now. We...
Read ArticleThe Dow Jones Industrial Average fell Thursday and snapped a 3-day win streak after the release of...
Read ArticleNote: Figures recorded at 7:40am AEDT. Updated figures and a video recording will be available at 9a...
Read ArticleBy Rudi Filapek-Vandyck, Editor FNArena M&A Is Back (With A Vengeance)Even the more casual obser...
Read ArticleASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essenti...
Read ArticleWelcome to the FNArena Corporate Results Monitor. Today's Reports: ((4DX)) - 4DMedical ((APM)) - A...
Read ArticleViking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on p...
Read ArticleXi and Biden set to agree on restricting fentanyl Fentanyl is a synthetic opioid responsible for t...
Read ArticleNews relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD f...
Read ArticleL’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supr...
Read ArticleMorgans says companies on the ASX are propelling our appetite product for health and wellness produ...
Read ArticleThe FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergenc...
Read ArticleThe Nasdaq Composite fell for a fourth session Thursday as concerns resurfaced over the Federal Re...
Read ArticleEarnings reports dominated headlines in August Despite solid results from ASX healthcare giants, th...
Read ArticleThe S&P 500 advanced Wednesday for a four-day winning streak, as investors assess new US econo...
Read ArticleAustralian biotech has attracted US investments in the last five years Among ASX stocks to get fund...
Read ArticleWelcome to the FNArena Corporate Results Monitor. Today's Reports: ((ALG)) - Ardent Leisure ((ABB)...
Read ArticleToday, Monday the 28th of August, we are happy to buy Wesfarmers (ASX:WES), Accent Group (ASX:AX1),...
Read ArticleFirebrick Pharma awaiting results of pivotal trial of its Nasodine nasal spray to treat the common...
Read ArticleBiotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two g...
Read ArticleThe end of pandemic and higher rates have subdued biotech market But there are signs now the sector...
Read ArticleBrisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “gam...
Read ArticleSmall cap health stocks are not known to pay dividends But there’s a handful of such stocks on the...
Read ArticleBiotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We...
Read ArticlePfizer said its diabetes drug works as well as Ozempic for weight loss What are the side effects of...
Read ArticleThe Federal Budget delivers billions of dollars funding into healthcare and aged care Mental health...
Read ArticleSmall-cap Probiotec Limited, which acts as a contract manufacturer for the likes of Pfizer and L’ore...
Read ArticleArtificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discove...
Read ArticleShareCafeUS stocks rise after banks look to bail out First Republic Stocks...
Read ArticleShareCafeS&P 500 closes lower as investors digest Feb’s losses The S&am...
Read ArticleWelcome to the FNArena Corporate Results Monitor. Today's Reports: ((ABY)) - Adore Beauty ((AIM))...
Read ArticleAlcidion increased sales significantly in the first half Cogstate sounds warning on outlook Probiot...
Read ArticleThe FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have g...
Read ArticleJapanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based devic...
Read ArticleASX health stocks have been out of favour this year with rotation away from growth to value sector...
Read ArticleWe take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks fr...
Read ArticleBlood clot programs have taken the spotlight recently as new discoveries made Two ASX health stocks...
Read ArticleHealthcare is one of those industries that enjoys relatively stable demand through tougher economic...
Read ArticleShareCafeUS markets rise as EV battery integration grows rapidly under Biden Administration ...
Read ArticleShareCafeMetal prices under pressure as recession looms across the globe US...
Read ArticleHealthcare giants Sonic and EBOS report solid full year results Trajan offers handy forward guidanc...
Read ArticleUS FDA approves the first clinical trial using naturally derived psychedelic drugs It could open po...
Read ArticleA recent research reveals which biotech segments VCs are ploughing billions of dollars into We list...
Read ArticleThe Healthcare sector has been struggling as the pandemic wanes But most money managers are still b...
Read ArticleThe healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak mark...
Read ArticleBiotech sector has had a tough time recently But there are signs of things improving this year A lo...
Read ArticleTelehealth was already a growing space even before the pandemic, but COVID had launched it into the...
Read ArticleThe ASX 200 Health Index (XHJ) is trading higher by 0.27% at the time of writing, compared to the br...
Read ArticleThe ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial t...
Read ArticleAt the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, be...
Read ArticleIt’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and...
Read ArticleThe life sciences sector has emerged into the spotlight ever since the pandemic began. In the US, th...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 los...
Read ArticleTrading Places is Stockhead’s recap of the buys and sells of ASX small cap shares by fund managers a...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 los...
Read ArticleTrading Places is Stockhead’s recap of the buys and sells of ASX small cap shares by fund managers a...
Read ArticleAlthough earnings results were the main theme in August, there were also some notable healthcare bre...
Read ArticleThe ASX 200 health stocks index (XHJ) rose by 0.60% this morning, compared to the broader index whic...
Read ArticleWall Street rises again as iron ore rebounds All three US stock market indexes rose last night to th...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 7...
Read ArticleThe ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 7...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52...
Read ArticleSummary The S&P/ASX200 ended lower by just 0.70 points at 7,307.30. The market sentiments w...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has ret...
Read ArticleThe S&P/ASX200 closed lower Wednesday, dropping 22.40 points or 0.31% to 7270.20 after setting a...
Read ArticleSummary The ASX 200 closed 22.40 points or 0.31% lower at 7,270.20, after setting a new 100-day...
Read ArticleAspiring pill-packer Probiotec [ASX:PBP] share price is up 7.18% today, rising on the back of upgrad...
Read ArticleAspiring pill-packer Probiotec Ltd [ASX:PBP] share price is up 7.18% today, rising on the back of up...
Read ArticleThe Probiotec Limited (ASX: PBP) share price is on the move during late afternoon trade. This comes...
Read ArticleWall Street little changed ahead of inflation data Major indices in the US were little changed last...
Read ArticleThe IDT Australia Limited (ASX: IDT) share price was on fire again on Monday. The pharmaceutical ma...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks f...
Read ArticleLocal outfit Probiotec Ltd [ASX:PBP] is up 18% at time of writing. Soaring on the back of new takeov...
Read ArticleProbiotec (ASX: PBP) has made what it calls a “strategic” bid for contract packing business Multipac...
Read ArticleThe Probiotec Limited (ASX: PBP) share price is shooting higher as the company presented its annual...
Read ArticleNot all change associated with a pandemic is bad. One thing that could potentially change for the be...
Read ArticleLast year, in July, pharmaceuticals company Probiotec (ASX:PBP) announced and completed a $23m acqui...
Read ArticleThe Probiotec Limited (ASX: PBP) share price continued its impressive run on Wednesday. It shares f...
Read ArticleGastrointestinal diseases are among the most inconvenient types of illnesses to have, and not just b...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleTrading Places is Stockhead’s weekly recap of substantial holder movements focusing on fund managers...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleShaw and Partners is pleased to announce that Probiotec Limited (ASX: PBP) has successfully complete...
Read ArticleASX-listed pharmaceuticals firm Probiotec was in front of fund managers on Wednesday, seeking to rai...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleWeight loss shakes maker Celebrity Slim has been sold by ASX-listed healthcare company Probiotec to...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticlePharmaceutical company Probiotec (ASX: PBP) has struck a deal worth at least $23 million to acquire...
Read ArticleShares in pharmaceutical drug maker Probiotec (ASX:PBP) have hit their highest point in nearly 10 ye...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
